|
1
|
Rivière D, Mancini J, Santini L, Giovanni
A, Dessi P and Fakhry N: Lymph-node metastasis following total
laryngectomy and total pharyngolaryngectomy for laryngeal and
hypopharyngeal squamous cell carcinoma: Frequency, distribution and
risk factors. Eur Ann Otorhinolaryngol Head Neck Dis. 135:163–166.
2018. View Article : Google Scholar
|
|
2
|
Krstevska V, Stojkovski I and Lukarski D:
Concurrent radiochemotherapy in advanced hypopharyngeal cancer.
Radiat Oncol. 5:392010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cabral RM and Baptista PV: Anti-cancer
precision theranostics: A focus on multifunctional gold
nanoparticles. Expert Rev Mol Diagn. 14:1041–1052. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aioub M and El-Sayed MA: A real-time
surface enhanced raman spectroscopy study of plasmonic photothermal
cell death using targeted gold nanoparticles. J Am Chem Soc.
138:1258–1264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brand TM, Iida M, Li C and Wheeler DL: The
nuclear epidermal growth factor receptor signaling network and its
role in cancer. Discov Med. 12:419–432. 2011.PubMed/NCBI
|
|
6
|
Zhang S, Li Y, He X, Dong S, Huang Y, Li
X, Li Y, Jin C, Zhang Y and Wang Y: Photothermolysis mediated by
gold nanorods modified with EGFR monoclonal antibody induces Hep-2
cells apoptosis in vitro and in vivo. Int J Nanomedicine.
9:1931–1946. 2014.PubMed/NCBI
|
|
7
|
Normanno N, De Luca A, Bianco C, Strizzi
L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F and
Salomon DS: Epidermal growth factor receptor (EGFR) signaling in
cancer. Gene. 366:2–16. 2006. View Article : Google Scholar
|
|
8
|
Garrett TP, McKern NM, Lou M, Elleman TC,
Adams TE, Lovrecz GO, Zhu HJ, Walker F, Frenkel MJ, Hoyne PA, et
al: Crystal structure of a truncated epidermal growth factor
receptor extracellular domain bound to transforming growth factor
alpha. Cell. 110:763–773. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sourbier C, Lindner V, Lang H, Agouni A,
Schordan E, Danilin S, Rothhut S, Jacqmin D, Helwig JJ and
Massfelder T: The phosphoinositide 3-kinase/Akt pathway: A new
target in human renal cell carcinoma therapy. Cancer Res.
66:5130–5142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hotfilder M, Sondermann P, Senss A, van
Valen F, Jürgens H and Vormoor J: PI3K/AKT is involved in mediating
survival signals that rescue Ewing tumour cells from fibroblast
growth factor 2-induced cell death. Br J Cancer. 92:705–710. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sandra CM, Eduardo CC, Simon HO, Teresa
RA, Antonio NC, Lijanova IV and Marcos MG: Anticancer activity and
anti-inflammatory studies of 5‑aryl‑1,4‑benzodiazepine derivatives.
Anticancer Agents Med Chem. 12:611–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clemens MJ: Targets and mechanisms for the
regulation of translation in malignant transformation. Oncogene.
23:3180–3188. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vignard J, Mirey G and Salles B:
Ionizing-radiation induced DNA double-strand breaks: A direct and
indirect lighting up. Radiother Oncol. 108:362–369. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ciccia A and Elledge SJ: The DNA damage
response: Making it safe to play with knives. Mol Cell. 40:179–204.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abraham RT: Cell cycle checkpoint
signaling through the ATM and ATR kinases. Genes Dev. 15:2177–2196.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Demoulin B, Hermant M, Castrogiovanni C,
Staudt C and Dumont P: Resveratrol induces DNA damage in colon
cancer cells by poisoning topoisomerase II and activates the ATM
kinase to trigger p53-dependent apoptosis. Toxicol In Vitro.
29:1156–1165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Cong L, He J, Wang Y, Zou Y, Yang
Z, Hu Y, Zhang S and He X: Photothermal treatment with
EGFRmAb-AuNPs induces apoptosis in hypopharyngeal carcinoma cells
via PI3K/AKT/mTOR and DNA damage response pathways. Acta Biochim
Biophys Sin (Shanghai). 50:567–578. 2018. View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Durr NJ, Larson T, Smith DK, Korgel BA,
Sokolov K and Ben-Yakar A: Two-photon luminescence imaging of
cancer cells using molecularly targeted gold nanorods. Nano Lett.
7:941–945. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dickerson EB, Dreaden EC, Huang X,
El-Sayed IH, Chu H, Pushpanketh S, McDonald JF and El-Sayed MA:
Gold nanorod assisted near-infrared plasmonic photothermal therapy
(PPTT) of squamous cell carcinoma in mice. Cancer Lett. 269:57–66.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Castellani R, Visscher DW, Wykes S, Sarkar
FH and Crissman JD: Interaction of transforming growth factor-alpha
and epidermal growth factor receptor in breast carcinoma. An
immunohistologic study. Cancer. 73:344–349. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giampieri R, Scartozzi M, Del Prete M,
Maccaroni E, Bittoni A, Faloppi L, Bianconi M, Cecchini L and
Cascinu S: Molecular biomarkers of resistance to anti-EGFR
treatment in metastatic colorectal cancer, from classical to
innovation. Crit Rev Oncol Hematol. 88:272–283. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bonner JA, Harari PM, Giralt J, Azarnia N,
Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, et al:
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head
and neck. N Engl J Med. 354:567–578. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bonner JA, Harari PM, Giralt J, Cohen RB,
Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, et al:
Radiotherapy plus cetuximab for locoregionally advanced head and
neck cancer: 5-year survival data from a phase 3 randomised trial,
and relation between cetuximab-induced rash and survival. Lancet
Oncol. 11:21–28. 2010. View Article : Google Scholar
|
|
25
|
Ahlmann E, Patzakis M, Roidis N, Shepherd
L and Holtom P: Comparison of anterior and posterior iliac crest
bone grafts in terms of harvest-site morbidity and functional
outcomes. J Bone Joint Surg Am. 84-A:716–720. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
LoPiccolo J, Blumenthal GM, Bernstein WB
and Dennis PA: Targeting the PI3K/Akt/mTOR pathway: effective
combinations and clinical considerations. Drug Resist Updat.
11:32–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Catasus L, D’Angelo E, Pons C, Espinosa I
and Prat J: Expression profiling of 22 genes involved in the
PI3K‑AKT pathway identifies two subgroups of high‑grade endometrial
carcinomas with different molecular alterations. Mod Pathol.
23:694–702. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Priulla M, Calastretti A, Bruno P,
Azzariti A, Paradiso A, Canti G and Nicolin A: Preferential
chemosensitization of PTEN-mutated prostate cells by silencing the
Akt kinase. Prostate. 67:782–789. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang D and Fan D: Multidrug resistance in
gastric cancer: Recent research advances and ongoing therapeutic
challenges. Expert Rev Anticancer Ther. 7:1369–1378. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang L, Dan HC, Sun M, Liu Q, Sun XM,
Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, et al:
Akt/protein kinase B signaling inhibitor-2, a selective small
molecule inhibitor of Akt signaling with antitumor activity in
cancer cells overexpressing Akt. Cancer Res. 64:4394–4399. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu X, Dai X and Wu B: Study of 5-Aza-CdR
on transcription regulation of RASSF1A gene in the BIU87 cell line.
Urol Int. 82:108–112. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liao W, McNutt MA and Zhu WG: The comet
assay: A sensitive method for detecting DNA damage in individual
cells. Methods. 48:46–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lieberman HB: DNA damage repair and
response proteins as targets for cancer therapy. Curr Med Chem.
15:360–367. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matsumoto K, Nagahara T, Okano J and
Murawaki Y: The growth inhibition of hepatocellular and
cholangiocellular carcinoma cells by gemcitabine and the roles of
extracellular signal-regulated and checkpoint kinases. Oncol Rep.
20:863–872. 2008.PubMed/NCBI
|
|
35
|
Aioub M, Panikkanvalappil SR and El-Sayed
MA: Platinum-coated gold nanorods: Efficient reactive oxygen
scavengers that prevent oxidative damage toward healthy, untreated
cells during plasmonic photothermal therapy. ACS Nano. 11:579–586.
2017. View Article : Google Scholar
|
|
36
|
Schieber M and Chandel NS: ROS function in
redox signaling and oxidative stress. Curr Biol. 24:R453–R462.
2014. View Article : Google Scholar : PubMed/NCBI
|
